Skip to main content
SpringerLink
Log in

Kutane Borreliosen

Erythema chronicum migrans, Lymphadenosis cutis benigna, Acrodermatitis chronica atrophicans

  • Chapter
Therapie der Hautkrankheiten

  • 227 Accesses

Zusammenfassung

Unter den kutanen Borreliosen werden hier 3 traditionelle Dermatosen zusammengefasst, deren Erstbeschreibung durch europäische Autoren anhand klinischer Kriterien bereits über 50 Jahre zurückliegt. Sie wurden frühzeitig als morphologische Entitäten erkannt, doch erst in den 80er Jahren gelang es aufzuzeigen, dass sie in ihrer Gesamtheit unterschiedliche Stadien bzw. Verlaufsformen einer Anthropozoonose darstellen, die durch Borrelien hervorgerufen wird. Es handelt sich um das Erythema chronicum migrans (ECM), die Lymphadenosis cutis benigna (LABC) und die Acrodermatitis chronica atrophicans (ACA). Während das ECM inzwischen zunehmend auch in anderen Kontinenten gesehen wird, blieb die ACA v. a. auf Mittel- bzw. Nordeuropa beschränkt und hat in manchen waldreichen Gegenden endemischen Charakter.

Erreger: Borrelia burgdorferi

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 378.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur zu Kapitel 4

  • Afzelius A (1921) Erythema chronicum migrans. Acta Derm Venereol 2:120–125

    Google Scholar 

  • Aguero RM, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP (1996) Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 34:1–9

    Google Scholar 

  • Anonymus (1999) Recommendations for the use of lyme disease vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 48:1–5

    Google Scholar 

  • Asbrink E, Hovmark A (1988) Early and late cutaneous manifestations of Ixodes-borne borreliosis (erythema migrans borreliosis, lyme borreliosis). Ann N Y Acad Sci 539:4–15

    Article  PubMed  CAS  Google Scholar 

  • Asbrink E, Hederstedt B, Hovmark A (1984) The spirochetal etiology of erythema chronicum migrans Afzelius. Acta Derm Venereol 64: 291–295

    PubMed  CAS  Google Scholar 

  • Asbrink E, Hovmark A, Hederstedt B (1984) The spirochetal etiology of acrodermatitis chronica atrophicans Herxheimer. Acta Derm Venereol 64:506–512

    PubMed  CAS  Google Scholar 

  • Asbrink E, Hovmark A, Olsson I (1986) Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients. Zentralbl Bakteriol 263:253–261

    CAS  Google Scholar 

  • Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A (1994) Lyme disease: an infectious and postinfectious syndrome. J Rheumatol 21:454–461

    PubMed  CAS  Google Scholar 

  • Bäfverstedt B (1943) Über Lymphadenosis benigna cutis. Eine klinische und pathologisch-anatomische Studie. Acta Derm Venereol 24 (Suppl 11): 1–102

    Google Scholar 

  • Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H (1998) Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 36: 2658–2665

    PubMed  CAS  Google Scholar 

  • Burgdorfer W, Barbour AG, Hayes SF et al. (1982) Lyme disease — a tickborne spirochetosis? Science 216:1317–1319

    Article  PubMed  CAS  Google Scholar 

  • Christen HJ (1996) Lyme neuroborreliosis in children. Ann Med 28: 235–240

    Article  PubMed  CAS  Google Scholar 

  • Dattwyler RJ, Halperin JJ, Pass H (1987) Ceftriaxone as effective therapy in refractory lyme disease. J Infect Dis 155:1322–1324

    Article  PubMed  CAS  Google Scholar 

  • Dattwyler RJ, Luft BJ, Kunkel MJ et al. (1997) Ceftriaxone compared with doxycycline for the treatment of acute disseminated lyme disease. N Engl J Med 337: 289–294

    Article  PubMed  CAS  Google Scholar 

  • Donta ST (1997) Tetracycline therapy for chronic lyme disease. Clin Infect Dis 25 (Suppl 1): S52–S56

    Article  Google Scholar 

  • Eckman MH, Steere AC, Kalish RA, Pauker SG (1997) Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early lyme disease or lyme arthritis. N Engl J Med 337:357–363

    Article  PubMed  CAS  Google Scholar 

  • Fawcett PT, Rose CD, Gibney KM, Doughty RA (1997) Correlation of seroreactivity with response to antibiotics in pediatric lyme borreliosis. Clin Diagn Lab Immunol 4: 85–88

    PubMed  CAS  Google Scholar 

  • Garbe C (1991): Borreliosen der Haut — Fortschritte der Kenntnis seit Entdeckung der Lyme-Krankheit. Hautarzt 42:356–365

    PubMed  CAS  Google Scholar 

  • Garbe C, Stein H, Dienemann D, Orfanos CE (1991) Borrelia burgdorferi-associated cutaneous B-cell-lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol 24:584–590

    Article  PubMed  CAS  Google Scholar 

  • Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL (1996) Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 335: 1270–1274

    Article  PubMed  CAS  Google Scholar 

  • Graninger W (1996) A „minority“ opinion about the diagnosis and treatment of lyme arthritis. Infection 24:95–97

    Article  PubMed  CAS  Google Scholar 

  • Graninger W (1999) Therapieindikation bei positivem Borrelientiter. Internist (Berl) 40:216

    CAS  Google Scholar 

  • Hammers BS, Lebech AM, Karlsson M, Andersson U, Hansen K, Stiernstedt G (1994) Serological follow-up after treatment of Borrelia arthritis and acrodermatitis chronica atrophicans. Scand J Infect Dis 26:339–347

    Article  Google Scholar 

  • Hammers BS, Lebech AM, Karlsson M, Svenungsson B, Hansen K, Stiernstedt G (1994) Serological follow-up after treatment of patients with erythema migrans and neuroborreliosis. J Clin Microbiol 32:1519–1525

    Google Scholar 

  • Hassler D, Riedel K, Zorn J, Preac-Mursic V (1991) Pulsed high-dose cefotaxime therapy in refractory lyme borreliosis. Lancet 338:193

    Article  PubMed  CAS  Google Scholar 

  • Hassler D, Zorn J, Zöller L et al. (1992) Noduläre Panni-kulitis: eine Verlaufsform der Lyme-Borreliose? Hautarzt 43:134–138

    PubMed  CAS  Google Scholar 

  • Herxheimer K, Hartmann K (1902) Über Acrodermatitis chronica atrophicans. Arch Dermatol Syph 6: 255

    Google Scholar 

  • Hobusch D, Christen HJ, Huppertz HI, Noack R (1999) Diagnostik und Therapie der Lyme-Borreliose im Kindesalter. Empfehlung der Deutschen Gesellschaft fur Padiatrische Infektiologie. Klin Padiatr 211:70–74

    Article  PubMed  CAS  Google Scholar 

  • Hoecke C van, Lebacq E, Beran J, Parenti D (1999) Alternative vaccination schedules (o, 1, and 6 months versus 0,1, and 12 months) for a recombinant OspA lyme disease vaccine. Clin Infect Dis 28:1260–1264

    Article  PubMed  Google Scholar 

  • Hofmann H (1996) Lyme borreliosis-problems of serological diagnosis. Infection 24:470–472

    Article  PubMed  CAS  Google Scholar 

  • Hovmark A, Asbrink E, Olsson I (1986) The spirochetal etiology of lymphadenosis benigna cutis solitaria. Acta Derm Venereol 66:479–484

    PubMed  CAS  Google Scholar 

  • Hulshof MM, Vandenbroucke JP, Nohlmans LM, Spanjaard L, Bavinck JN, Dijkmans BA (1997) Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans. Arch Dermatol 133:33–37

    Article  PubMed  CAS  Google Scholar 

  • Kalish RA, Leong JM, Steere AC (1993) Association of treatment-resistant chronic lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect Immun 61: 2774–2779

    PubMed  CAS  Google Scholar 

  • Krbkova L, Stanek G (1996) Therapy of lyme borreliosis in children. Infection 24:170–173

    Article  PubMed  CAS  Google Scholar 

  • Liegner KB, Shapiro JR, Ramsay D et al. (1993) Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting borrelia burgdorferi infection. J Am Acad Dermatol 28:312–314

    Article  PubMed  CAS  Google Scholar 

  • Luft BJ, Dattwyler RJ, Johnson RC et al. (1996) Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial. Ann Intern Med 124:785–791

    Article  PubMed  CAS  Google Scholar 

  • Magid D, Schwartz B, Craft I, Schwartz JS (1992) Prevention of lyme disease after tick bites. A cost-effectiveness analysis. N Engl J Med 327:534–541

    Article  PubMed  CAS  Google Scholar 

  • Maraspin V, Cimperman J, Lotric FS, Pleterski RD, Strie F (1996) Treatment of erythema migrans in pregnancy. Clin Infect Dis 22:788–793

    Article  PubMed  CAS  Google Scholar 

  • Muellegger R, Zoechling N, Soyer HP, Hoedl S, Wienecke R, Volkenandt M, Kerl H (1995) No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment. Arch Dermatol 131:678–682

    Article  PubMed  CAS  Google Scholar 

  • Muellegger R, Zoechling N, Schluepen EM, Soyer HP, Hoedl S, Kerl H, Volkenandt M (1996) Polymerase chain reaction control of antibiotic treatment in dermato-borreliosis. Infection 24:76–79

    Article  PubMed  CAS  Google Scholar 

  • Nadelman RB, Wormser GP (1995) Erythema migrans and early lyme disease. Am J Med 98:15S–23S

    Article  Google Scholar 

  • Nadelman RB, Wormser GP (1998) Lyme borreliosis. Lancet 352:557–565

    Article  PubMed  CAS  Google Scholar 

  • Nadelman RB, Nowakowski J, Forseter G et al. (1996) The clinical spectrum of early lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med 100:502–508

    Article  PubMed  CAS  Google Scholar 

  • Nichol G, Dennis DT, Steere AC, Lightfoot R, Wells G, Shea B, Tugwell P (1998) Test-treatment strategies for patients suspected of having lyme disease: a cost-effectiveness analysis. Ann Intern Med 128:37–48

    Article  PubMed  CAS  Google Scholar 

  • Olsson I, Asbrink E, von-Stedingk M, von-Stedingk LV (1994) Changes in Borrelia burgdorferi-specific serum IgG antibody levels in patients treated for acrodermatitis chronica atrophicans. Acta Derm Venereol 74: 424–428

    PubMed  CAS  Google Scholar 

  • Onrust SV, Goa KL (2000) Adjuvanted lyme disease vaccine: a review of its use in the management of lyme disease. Drugs 59:281–299

    Article  PubMed  CAS  Google Scholar 

  • Plorer A, Sepp N, Schmutzhard E et al. (1993) Effects of adequate versus inadequate treatment of cutaneous manifestations of lyme borreliosis on the incidence of late complications and late serologic status. J Invest Dermatol 100:103–109

    Article  PubMed  CAS  Google Scholar 

  • Sigal LH (1992) Current recommendations for the treatment of lyme disease. Drugs 43: 683–699

    Article  PubMed  CAS  Google Scholar 

  • Steere AC (1997) Diagnosis and treatment of lyme arthritis. Med Clin North Am 81:179–194

    Article  PubMed  CAS  Google Scholar 

  • Steere AC, Taylor E, McHugh GL, Logigian EL (1993) The overdiagnosis of lyme disease. JAMA 269:1812–1816

    Article  PubMed  CAS  Google Scholar 

  • Steere AC, Levin RE, Molloy PJ, Kalish RA, Abraham JH, Liu NY, Schmid CH (1994) Treatment of lyme arthritis. Arthritis Rheum 37: 878–888

    Article  PubMed  CAS  Google Scholar 

  • Strle F, Maraspin V, Lotric FS, Ruzic SE, Cimperman J (1996) Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans. Infection 24: 64–68

    Article  PubMed  CAS  Google Scholar 

  • Svenungsson B, Lindh G (1997) Lyme borreliosis-an overdiagnosed disease? Infection 25:140–143

    Article  PubMed  CAS  Google Scholar 

  • Verdon ME, Sigal LH (1997) Recognition and management of lyme disease. Am Fam Physician 56:427–440

    PubMed  CAS  Google Scholar 

  • von-Stedingk LV, Olsson I, Hanson HS, Asbrink E, Hovmark A (1995) Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late lyme borreliosis. Eur J Clin Microbiol Infect Dis 14:1–5

    Article  PubMed  CAS  Google Scholar 

  • Wahlberg P (1999) Vaccination against lyme borreliosis. Ann Med 31:233–235

    Article  PubMed  CAS  Google Scholar 

  • Wahlberg P, Granlund H, Nyman D, Panelius J, Seppala I (1993) Late lyme borreliosis: epidemiology, diagnosis and clinical features. Ann Med 25:349–352

    Article  PubMed  CAS  Google Scholar 

  • Wang G, Dam AP van, Schwartz I, Dankert J (1999) Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 12:633–653

    PubMed  CAS  Google Scholar 

  • Weber K (1996) Treatment failure in erythema migrans -a review. Infection 24:73–75

    Article  PubMed  CAS  Google Scholar 

  • Weber K, Wilske B, Preac M, V, Thurmayr R (1993) Azithromycin versus penicillin V for the treatment of early lyme borreliosis. Infection 21:367–372

    Article  PubMed  CAS  Google Scholar 

  • Weide B, Schittek B, Klyscz T et al. (1999) Morphaea is neither associated to features of Borrelia burgdorferi infection nor is this agent detectable in lesional skin by polymerase chain reaction. Br J Dermatol (im Druck)

    Google Scholar 

  • Weide B, Walz T, Garbe C (2000) Is morphaea caused by Borrelia burgdorferi ? — A review. Br J Dermatol (im Druck)

    Google Scholar 

  • Weiss M (1998) Lyme-Borreliose. Ther Umsch 55:45–51

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie, Universitätsklinikum Benjamin Franklin Freie Universität Berlin, Fabeckstr. 60-62, 14195, Berlin, Deutschland

    Prof. Dr. Prof. h. c. Constantin E. Orfanos

  2. Hautklinik und Poliklinik, Eberhard-Karls-Universität, Liebermeisterstr. 25, 72076, Tübingen, Deutschland

    Prof. Dr. Claus Garbe

Authors
  1. Prof. Dr. Prof. h. c. Constantin E. Orfanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. Claus Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

U. Blume-Peytavi C. C. Geilen S. Goerdt H. Gollnick E. Haneke F.-M. Köhn B. Tebbe R. Treudler Ch. C. Zouboulis

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Orfanos, C.E., Garbe, C. (2002). Kutane Borreliosen. In: Blume-Peytavi, U., et al. Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56219-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56219-8_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62541-1

  • Online ISBN: 978-3-642-56219-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation